Drawing for SEXTEGEN IS A DIETARY SUPPLEMENT, AT THE END OF WORD SEXTEGEN WHERE LETTER "N" ENDS POSSESS A BIOLOGICAL SIGN; UNDERNEATH WORD SEXTEGEN HAS THREE LINES AND A LARGE "X". WORD SEXTEGEN REPRESENT IN YELLOW COLOR SEXTEGEN BIOLOGICAL SYMBOL IS NEITHER GENERIC

USPTO serial 85016577

SEXTEGEN IS A DIETARY SUPPLEMENT, AT THE END OF WORD SEXTEGEN WHERE LETTER "N" ENDS POSSESS A BIOLOGICAL SIGN; UNDERNEATH WORD SEXTEGEN HAS THREE LINES AND A LARGE "X". WORD SEXTEGEN REPRESENT IN YELLOW COLOR SEXTEGEN BIOLOGICAL SYMBOL IS NEITHER GENERIC

Reviewed by CopyMark Law Group

Status 622
Filing date
—
Status date
Registration date
—
Examiner
—
Law office
UNKNOWN

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SEXTEGEN IS A DIETARY SUPPLEMENT, AT THE END OF WORD SEXTEGEN WHERE LETTER "N" ENDS POSSESS A BIOLOGICAL SIGN; UNDERNEATH WORD SEXTEGEN HAS THREE LINES AND A LARGE "X". WORD SEXTEGEN REPRESENT IN YELLOW COLOR SEXTEGEN BIOLOGICAL SYMBOL IS NEITHER GENERIC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

The Amin law Group, LTD

THE AMIN LAW GROUP, LTD AMIN LAW GROUP, LTD2211 MICHELSON DRIVE1708 EAST NORTH BAY ST, TAMPA, FL 33610IRVINE, CA 92612

Goods and services

ClassDescriptionStatusFirst use
005Dietary and nutritional supplementsACTIVEJun 17, 2006

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 21, 2010NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance